Bill 32 requires Manitoba’s cancer authority to produce two formal plans: a screening plan that defines who is at increased risk and should receive earlier or more intensive screening, and an access plan that targets outreach and service expansion for communities facing barriers. Both plans must be produced within six months of royal assent and updated every five fiscal years.
The law also mandates ongoing public education, annual joint reporting by the cancer authority and the provincial health authority with disaggregated operational data, and gives the minister authority to request plan changes and make regulations. The provisions explicitly prioritize outreach to Black, Indigenous and people of colour and other populations identified by demographic or geographic barriers.
At a Glance
What It Does
The bill requires the cancer authority to develop a risk-based screening plan and a province-wide access plan within six months of coming into force, update both every five fiscal years, and provide annual joint reports with specific data elements to the minister.
Who It Affects
The cancer authority and provincial health authority carry primary responsibilities; the minister gains oversight and regulatory power. Clinicians, screening programs, mobile mammography services, and communities identified as underserved — including Black, Indigenous and people of colour — are directly affected.
Why It Matters
This statute moves Manitoba from ad hoc programs to formal planning with targets and public reporting, tying equity priorities to operational planning and creating administrative levers (regulations, ministerial change requests) that can influence clinical implementation and resource allocation.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Bill 32 sets up two required planning instruments. The screening plan must define criteria for who counts as “increased risk” and outline how clinical guidelines will be reviewed to change eligibility.
That means the cancer authority must translate clinical guidance into concrete eligibility rules — for example, age adjustments, family-history thresholds, genetic-risk indicators or other markers the authority chooses to adopt — and commit to a review cadence tied to guideline updates.
The access plan is explicitly about removing barriers and raising participation. It must identify communities with limited access (the law singles out Black, Indigenous and people of colour as priorities), explain how those communities were identified (demographics or geography), propose ways to mitigate barriers, and establish annual participation targets.
The statute anticipates mobile screening and other location-specific measures by requiring the plans to consider and report on screening delivered by location.Operational transparency is a core mechanism. Starting in the 2027 fiscal year the cancer authority and the provincial health authority must submit a joint annual report within 180 days after year-end that includes total mammograms and referrals, breakdowns by location (including mobile units) and by age, and participation-rate metrics.
The minister must table that report in the Legislative Assembly on one of the first 15 sitting days after receipt, creating a public accountability loop.The bill gives the minister regulatory authority to specify plan contents and reporting requirements and the power to request changes to the plans; the cancer authority must implement those changes “as soon as practicable.” The cancer authority also has an express duty to provide continuous public education, taking account of priorities in the access plan. The act comes into force on royal assent and requires plan updates every fifth fiscal year thereafter.
The Five Things You Need to Know
The cancer authority must deliver both a screening plan and an access plan within six months after the act comes into force and update each plan every five fiscal years.
Annual joint reports (cancer authority + provincial health authority) must be filed within 180 days after the end of the 2027 fiscal year and each year after, and must include total mammograms and referrals plus disaggregation by location (including mobile units) and by age.
The access plan must identify and prioritize communities with limited access—explicitly listing Black, Indigenous and people of colour as priority groups—and set annual screening participation targets for those populations.
The minister may request changes to the plans and the cancer authority is required to implement requested changes “as soon as practicable,” and may also make regulations defining plan contents and reporting elements.
The cancer authority must provide continuous public breast cancer awareness and education, and the access plan must propose methods to mitigate identified barriers to mammography access.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Definitions that frame duties and actors
Section 1 defines key terms used through the Act: the cancer authority and provincial health authority are tied back to The Health System Governance and Accountability Act, and introduces “screening plan” and “access plan.” That linkage matters because it anchors responsibilities in existing governance structures and clarifies which statutory bodies carry operational obligations under this new law.
Screening plan: content and cadence
Section 2 requires the cancer authority to develop a plan to screen for increased breast cancer risk within six months and to refresh it every five fiscal years. The plan must set eligibility criteria for earlier or more intensive screening and specify how clinical guidelines will be reviewed to adjust those criteria. Practically, this forces the authority to codify risk thresholds and a process for aligning them with changing evidence.
Access plan: targeting, barriers and targets
Section 3 compels the cancer authority to build an access plan — also within six months and on a five-year refresh schedule — that identifies and prioritizes underserved communities (explicitly including Black, Indigenous and people of colour), catalogs barriers to mammography, proposes mitigation methods, and sets annual participation-rate targets. The statutory focus on demographic or geographic identification creates a planning requirement that links data analysis to outreach strategy and resource allocation.
Ministerial review, change requests and public education
Section 4 gives the minister the right to request copies of either plan and to require changes; the cancer authority must implement requested changes as soon as practicable. Section 5 separately obliges the cancer authority to maintain continuous public breast cancer awareness and education, explicitly tying educational priorities back to the access plan. Together these provisions insert ministerial oversight into both the content and operational priorities of screening programs.
Annual joint reporting and Assembly tabling
Section 6 mandates a joint annual report from the cancer authority and provincial health authority within 180 days after the end of the 2027 fiscal year and thereafter. Required data include total mammograms and referrals, breakdowns by location (including mobile screening) and by age, and screening participation rates; the minister may require additional information. The minister must table the report within the first 15 sitting days after receipt, ensuring legislative visibility of operational outcomes.
Regulations, citation and commencement
Section 7 grants broad regulatory authority to the minister to define plan and report contents, add required information, and clarify terminology used in the Act. Section 8 provides the consolidation citation; Section 9 sets commencement at royal assent. The regulatory provision is a key implementation lever because it allows the minister to fill gaps the Act leaves intentionally broad.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Individuals at increased clinical risk of breast cancer — Because the screening plan must define and operationalize eligibility for earlier or more intensive screening, people with family history, genetic markers or other risk indicators should gain clearer pathways to earlier detection.
- Black, Indigenous and people of colour and other identified underserved communities — The access plan requires identification, prioritization and targeted mitigation strategies, which can focus outreach, mobile services and education where participation lags.
- Public health planners and program managers — The required data disaggregation (by location, mobile screening and age) and annual targets give planners clearer performance metrics to allocate resources and evaluate interventions.
- Community organizations and advocacy groups — Statutory recognition of priority communities and an explicit duty for continuous public education create opportunities for partnerships and funding to run outreach and awareness campaigns.
Who Bears the Cost
- Cancer authority — The authority must produce and update two complex plans, collect more granular data, implement ministerial change requests rapidly and carry ongoing public education obligations, all of which increase administrative and operational load.
- Provincial health authority and screening providers — Joint reporting, expanded mobile screening and efforts to raise participation will increase program delivery costs, scheduling complexity and staff time in clinics and mobile units.
- Provincial treasury (public budget) — Meeting participation targets, expanding mobile services, funding outreach and supporting data systems may require new or reallocated funding that the Act does not itself appropriate.
- Smaller or rural health facilities — If the access plan centralizes outreach or redistributes screening resources, small clinics may face increased referral flows, capacity constraints or the need to upgrade equipment and training.
Key Issues
The Core Tension
The bill balances two legitimate goals — applying evidence-based, clinically tailored screening and using administrative levers to improve equity and population-level participation — but the mechanisms that enforce equity (targets, ministerial oversight, regulations) can conflict with clinical judgment, resource realities, and privacy constraints; resolving those conflicts requires careful implementation rather than more legislation.
The Act sets administrative duties and reporting lines but leaves critical substantive decisions — notably the definition of “increased risk,” the design of mitigation methods, and the precise content of reports — to the cancer authority and minister (including by regulation). That creates two implementation risks: (1) considerable variability in how risk thresholds and access priorities are operationalized across time and political cycles, and (2) a dependence on ministerial rule-making to provide technical clarity that clinicians and program managers will need to implement the plans.
Operational capacity is another central challenge. The statute expects the cancer authority to deliver plans within six months and to implement ministerial changes “as soon as practicable,” yet Manitoba’s existing mammography capacity, workforce availability and mobile screening infrastructure may constrain realistic roll‑out.
Data disaggregation requirements improve targeting but raise privacy and small-cell disclosure concerns when reporting by narrow demographic or geographic slices. Finally, the law creates incentive pressure: annual participation targets can drive useful focus, but poorly designed targets risk gaming, cherry-picking, or diverting resources from other parts of cancer care without additional funding or clear implementation metrics.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.